×
Including results for tmdx investor relations
Search only for dmtx investor relations
The Investor Relations website contains information about TransMedics's business for stockholders, potential investors, and financial analysts.
Missing: dmtx | Show results with:dmtx
Investor Resources · Investor FAQs · Email Alerts · Contact IR. Select Page. Patients ... TransMedics Investor Presentation - February 2024 · Privacy Policy ...
Missing: dmtx | Show results with:dmtx
Our DMTx program explores legal psychedelic research and exploration opportunities that are congruent with the needs and interests of the psychedelic community.
Missing: investor | Show results with:investor
Oct 3, 2017 · (NASDAQ:DMTX) ("Dimension") today announced ... (NASDAQ:DMTX) is a leader in discovering and ... Contacts for Ultragenyx: Investor Relations:
People also ask
Investor Relations: Ryan Martins. 415-483-8257. Media Relations: Joele Frank, Wilkinson Brimmer Katcher. Tim Lynch / Trevor Gibbons / Leigh Parrish. 212-355 ...
DTX101 is our lead gene therapy product candidate designed to deliver FIX gene expression in patients with hemophilia B. Hemophilia B is a rare genetic bleeding ...
(NASDAQ:DMTX) ("Dimension") Board of Directors that Ultragenyx's most recent ... Investor Relations: Ryan Martins 415-483-8257. Media Relations: Joele Frank ...
Healthcare Investor Conference 2024 Toronto ... InflaRx Appoints Jan Medina as Head of Investor Relations ... (Nasdaq: DMTX). Web page https://www.dimensiontx ...
View real-time Dimension Therapeutics Inc (DMTX) share prices and assess historical data, charts, technical analysis, performance reports and NASDAQ DMTX ...
Headquartered in Singapore, TDCX provides transformative digital CX solutions, enabling world-leading and disruptive brands to acquire new customers, to build ...
Missing: dmtx | Show results with:dmtx